LEQEMBI
Drug timelines are a Plus or Pro feature.
20 regulatory and trial events tracked for LEQEMBI, covering 2023-01-06 to 2026-08-05. Get the full timeline:
Most recent: EMA Authorised: Leqembi (Lecanemab) — Eisai GmbH
20 regulatory and trial events tracked for LEQEMBI, covering 2023-01-06 to 2026-08-05. Get the full timeline:
Most recent: EMA Authorised: Leqembi (Lecanemab) — Eisai GmbH